Nihon Chouzai Co (3341.T) Stock Price
Nihon Chouzai Co Price
Over the last 19 years Nihon Chouzai Co grew revenue by 10.0% annually, reaching 360.51 B JPY. Earnings per share have declined at 3.6% per year over the last 19 years. For Nihon Chouzai Co, the net margin of 0.4% is broadly stable versus 1.3% a few years ago. At today's price the dividend yield works out to roughly 0.64%. The payout ratio is around 54% of earnings. The dividend has grown at 3.3% per year over the past 19 years.
Nihon Chouzai Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Nihon Chouzai Co business model & stock analysis
Frequently asked questions about Nihon Chouzai Co
Nihon Chouzai Co Ltd operates as a pharmaceutical wholesaler in Japan. Nihon Chouzai is focused on providing a wide range of products and services to support the pharmaceutical industry. The company's business model revolves around sourcing and distributing pharmaceutical products to pharmacies, hospitals, and medical institutions. Nihon Chouzai aims to ensure the availability of high-quality pharmaceuticals, enhance logistical efficiency, and contribute to the overall improvement of healthcare in Japan. As a leading player in the Japanese pharmaceutical wholesale market, Nihon Chouzai's business model is centered on delivering reliable and efficient pharmaceutical supply chain solutions to meet the diverse needs of healthcare providers across the country.
Nihon Chouzai Co Ltd is primarily active in the pharmaceutical and healthcare industries.
The main competitors of Nihon Chouzai Co Ltd in the market include companies like Medipal Holdings Corporation, M3 Inc., and Medinet Co Ltd. These companies also operate in the pharmaceutical and healthcare industry, providing similar services and solutions.
Nihon Chouzai Co Ltd is a Japanese company with a rich history and background in the pharmaceutical industry. Established in 1959, Nihon Chouzai has been a key player in the distribution of pharmaceutical products throughout Japan. The company focuses on providing medicines and healthcare products to hospitals, clinics, and pharmacies, ensuring the availability of essential treatments to the Japanese population. With its extensive network and expertise in the pharmaceutical field, Nihon Chouzai has built strong relationships with various pharmaceutical manufacturers and suppliers, allowing them to consistently deliver quality products and contribute to the overall healthcare system in Japan.
Nihon Chouzai Co Ltd, a leading company in the pharmaceutical industry, has achieved several significant milestones. Over the years, the company has successfully expanded its operations, established a strong market presence, and achieved consistent revenue growth. Nihon Chouzai has also actively pursued strategic partnerships and collaborations, enabling it to enhance its product portfolio and strengthen its competitive position. Furthermore, the company has invested in research and development, leading to the introduction of innovative and high-quality pharmaceutical products. Nihon Chouzai's commitment to exceptional customer service and its strong focus on innovation has solidified its reputation as a trusted and reliable player in the pharmaceutical sector.
Nihon Chouzai Co Ltd is primarily present in Japan.
Nihon Chouzai Co Ltd represents a set of values and corporate philosophy that underpin its operations. The company focuses on promoting health and well-being by providing comprehensive pharmaceutical services and products. Nihon Chouzai Co Ltd is committed to offering high-quality healthcare solutions to its customers, ensuring their satisfaction and trust. With a strong emphasis on integrity, innovation, and professionalism, the company aims to contribute to society through its dedication to improving people's lives. Nihon Chouzai Co Ltd's corporate philosophy revolves around customer-centricity, continuous improvement, and fostering partnerships with stakeholders.
7 analysts currently rate the Nihon Chouzai Co stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Nihon Chouzai Co to generate revenue of 383.90 B JPY and earnings per share of 143.70 JPY.
Converted at the current exchange rate, the Nihon Chouzai Co share trades at 22.23 EUR (3,910.00 JPY).
The Nihon Chouzai Co share (3341.T) is listed on 1 stock exchanges, including: Tokio (JPX) (3341.T).
Nihon Chouzai Co Ltd is a company specializing in the sale of pharmaceuticals and medical products. It was founded in 1976 and has its headquarters in Tokyo, Japan. The company is divided into various divisions to offer a wide range of products to its customers. These divisions include health products, medical devices, clinical studies, and distribution. The health products division is one of the most comprehensive at Nihon Chouzai. The company offers an extensive selection of pharmaceuticals, dietary supplements, and health products. This also includes products for cosmetic purposes such as skincare products and sunscreen. Another important aspect of the health products division is customer education and consultation. Nihon Chouzai works closely with doctors and pharmacists to provide them with the best care and advice possible. The medical devices division focuses on the sale of devices used in medical practice. The product range includes diagnostic devices, patient treatment instruments, and medical imaging products. In this sector as well, Nihon Chouzai offers comprehensive consultation and training for doctors and medical personnel. Another important area for Nihon Chouzai is the conduct of clinical studies. The company offers its customers a comprehensive range of services and support in conducting clinical studies. This includes planning, implementation, monitoring, and reporting on clinical studies. In the distribution sector, Nihon Chouzai works closely with pharmaceutical manufacturers to market their products. Distribution is mainly done through pharmacies and medical facilities. Here, the company is strongly focused on customer retention and care, working closely with doctors and pharmacists to provide their customers with the best advice and care possible. Overall, Nihon Chouzai's business model is focused on the health and medical sectors. The company is dedicated to the development and marketing of pharmaceuticals and medical products to improve the health and well-being of people. It works closely with doctors and medical personnel to provide the best possible care and advice. The company has earned a reputation for the quality of its products and services and is committed to providing its customers with innovative solutions and top-notch customer service.
The expected revenue of Nihon Chouzai Co is 383.90 B JPY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Nihon Chouzai Co is 4.30 B JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Nihon Chouzai Co is currently 27.21. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nihon Chouzai Co stock.
The price-to-sales ratio (P/S) of Nihon Chouzai Co is currently 0.30. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nihon Chouzai Co stock.
The Eulerpool Quality Score for Nihon Chouzai Co is 4/10.
The ISIN of Nihon Chouzai Co is JP3729200000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Nihon Chouzai Co is A0B8SZ. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Nihon Chouzai Co is 3341.T. The ticker symbol is used to trade Nihon Chouzai Co shares on the stock exchange.
Nihon Chouzai Co stock
Nihon Chouzai Co Peer Group
Nihon Chouzai Co Ticker
Nihon Chouzai Co FIGI
All fundamentals and in-depth analysis of Nihon Chouzai Co
Our stock analysis for Nihon Chouzai Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nihon Chouzai Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.